Kotake, M <br/><br/>
High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  03 2017 
 - 669-670 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdw647  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylamides<br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma of Lung<br/>Aged<br/>Aniline Compounds<br/>Antibodies, Monoclonal--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Female<br/>Humans<br/>Incidence<br/>Lung Diseases, Interstitial--chemically induced<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Nivolumab<br/>Piperazines--administration & dosage